DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 804 filers reported holding DANAHER CORPORATION in Q3 2013. The put-call ratio across all filers is 0.51 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $3,622 | +7.3% | 14,498 | +7.3% | 0.16% | +1.3% |
Q1 2024 | $3,375 | +14.0% | 13,515 | +5.6% | 0.16% | +6.0% |
Q4 2023 | $2,961 | +12.6% | 12,801 | +20.8% | 0.15% | +2.1% |
Q3 2023 | $2,629 | +9.5% | 10,596 | +6.0% | 0.15% | +9.8% |
Q2 2023 | $2,400 | +1.8% | 9,999 | +6.9% | 0.13% | -1.5% |
Q1 2023 | $2,357 | -6.1% | 9,350 | -1.2% | 0.14% | -11.8% |
Q4 2022 | $2,511 | -99.9% | 9,459 | -2.0% | 0.15% | -11.0% |
Q3 2022 | $2,492,000 | +1.5% | 9,650 | -0.3% | 0.17% | +0.6% |
Q2 2022 | $2,455,000 | -14.0% | 9,682 | -0.6% | 0.17% | -5.5% |
Q1 2022 | $2,856,000 | -8.4% | 9,739 | +2.7% | 0.18% | -4.2% |
Q4 2021 | $3,119,000 | +7.3% | 9,482 | -0.7% | 0.19% | -1.0% |
Q3 2021 | $2,907,000 | +16.3% | 9,550 | +2.6% | 0.19% | +13.7% |
Q2 2021 | $2,499,000 | +23.6% | 9,309 | +3.7% | 0.17% | +20.0% |
Q1 2021 | $2,022,000 | +11.3% | 8,981 | +9.9% | 0.14% | -11.9% |
Q4 2020 | $1,816,000 | -15.8% | 8,173 | -18.4% | 0.16% | -22.4% |
Q3 2020 | $2,156,000 | +27.7% | 10,014 | +4.9% | 0.20% | +15.8% |
Q2 2020 | $1,688,000 | +25.0% | 9,547 | -2.1% | 0.18% | +6.6% |
Q1 2020 | $1,350,000 | -12.6% | 9,755 | -3.0% | 0.17% | +8.5% |
Q4 2019 | $1,544,000 | +10.6% | 10,057 | +4.0% | 0.15% | +3.4% |
Q3 2019 | $1,396,000 | -14.8% | 9,672 | -15.6% | 0.15% | -16.9% |
Q2 2019 | $1,638,000 | +0.6% | 11,457 | -7.2% | 0.18% | -5.3% |
Q1 2019 | $1,629,000 | +45.4% | 12,340 | +13.6% | 0.19% | +27.9% |
Q4 2018 | $1,120,000 | -97.8% | 10,866 | +1546.4% | 0.15% | +1125.0% |
Q3 2014 | $50,146,000 | -3.5% | 660 | 0.0% | 0.01% | -7.7% |
Q2 2014 | $51,961,000 | +5.0% | 660 | 0.0% | 0.01% | 0.0% |
Q1 2014 | $49,500,000 | -2.8% | 660 | 0.0% | 0.01% | -7.1% |
Q4 2013 | $50,952,000 | +11.4% | 660 | 0.0% | 0.01% | 0.0% |
Q3 2013 | $45,751,000 | +9.5% | 660 | 0.0% | 0.01% | +7.7% |
Q2 2013 | $41,778,000 | +1.9% | 660 | 0.0% | 0.01% | -7.1% |
Q1 2013 | $41,019,000 | – | 660 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
Third Point | 3,570,000 | $494,124,000 | 7.88% |